Author Archives: SPRIM GLOBAL INVESTMENTS

The Critical Need For Virtual Covid 19 Clinical Trials And Patient Training

DIGITAL CLINICAL SOLUTION

The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training
June 23, 2020

The FDA recently released new guidance on drug development for the prevention and treatment of COVID-19, emphasizing...

Read more
Obviohealth And Hôpital Paris Saint Joseph Announce Partnership To Track Covid 19 In Oncology Patients

DIGITAL CLINICAL SOLUTION

ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients
June 18, 2020

PARIS — June 18, 2020 – ObvioHealth, a full-service virtual research organization (VROTM), announces today...

Read more
Travecta Therapeutics Announces It Has Closed Its Oversubscribed Series A Round At $27 Million

BIOTECH

Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million
June 11, 2020

NEW YORK and SINGAPORE – June 11, 2020 – Travecta Therapeutics, a biopharmaceutical company pioneering...

Read more
Sprim Partners With Health Catalyst To Analyze Covid 19 Impact On Nash And Nafld

R&D SERVICES/CRO

SPRIM Partners with Health Catalyst to Analyze COVID-19 Impact on NASH and NAFLD
June 8, 2020

SPRIM and Health Catalyst partner to jumpstart understanding of COVID-19 impact on NASH and NAFLD...

Read more
Sgi Portfolio Logo Obviohealth

DIGITAL CLINICAL SOLUTION

ObvioHealth Secures $17 Million in Latest Investment Round
May 20, 2020

SINGAPORE and NEW YORK – May 20, 2020 – ObvioHealth, a leading virtual health research organization...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept